<DOC>
	<DOCNO>NCT00572494</DOCNO>
	<brief_summary>Prospective , multicenter , randomize clinical trial , Follow-up 1- , 6- 12 month This clinical investigation first design demonstrate safety effectiveness MAGIC EXPLORER stent system . The primary objective study evaluate safety 6-month patency bioabsorbable MAGIC EXPLORER stent patient stenotic occlusive atherosclerotic disease infrapopliteal artery . Secondary endpoint procedural success , patency follow-up , late lumen loss limb-salvage rate . Peri-procedural complication ( within 24 hour ) evaluate . Furthermore , data balloon catheter PLEON EXPLORER collect demonstrate effectiveness safety .</brief_summary>
	<brief_title>AMS INSIGHT 1 Study - Bioabsorbable Metal Stent Investigation Chronic Limb Ischemia Treatment</brief_title>
	<detailed_description />
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Peripheral Arterial Disease</mesh_term>
	<criteria>Stenotic ( &gt; 50 % ) occlusive atherosclerotic disease infrapopliteal artery Length lesion &lt; 20mm ( less one stent length ) Reference vessel diameter 3.03.5 mm A maximum two lesion one infrapopliteal vessel treat within study , two vessel two different leg . ( PTA treatment infrapopliteal lesion nonstudy vessel allow outside study ) . Symptomatic critical limb ischemia ( Rutherford 4 , 5 ) The patient must â‰¥ 50 year . Lifeexpectancy 6 month The subject legal guardian inform nature study ; agree provision sign informed consent The patient must available appropriate followup time duration study The patient capable follow study requirement . Patient refuse treatment The reference segment diameter suitable available stent design Length lesion require one stent implantation Previously implant stent ( ) PTA lesion site Lesion lie within adjacent aneurysm Inflowlimiting arterial lesion leave untreated The patient know allergy heparin , Aspirin anticoagulant/antiplatelet therapy bleed diatheses unable , unwilling , tolerate therapy . The patient take Phenprocoumon ( Marcumar ) . The patient history prior lifethreatening contrast medium reaction . The patient currently enrol another investigational device drug trial . The patient currently breastfeed , pregnant intend become pregnant . The patient mentally ill retard . The patient liable military civilian service .</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2008</verification_date>
	<keyword>Tibial artery</keyword>
	<keyword>Absorbable implant</keyword>
	<keyword>Stents</keyword>
	<keyword>Limb salvage</keyword>
</DOC>